Anubha Agarwal, MD, MSc

Related Links

Research Profile

Education

• Columbia University, Biology, Human Rights, BA: New York, NY (2008)
• Stanford University Graduate School of Business, Ignite Innovation Program, Certificate: Stanford, CA (2010)
• Stanford University School of Medicine, MD: Stanford, CA (2014)
• Duke University, Global Health Science, MSc: Durham, NC (2018)
• Duke University Medical Center, Residency, Internal Medicine-Global Health: Durham, NC (2018)
• Northwestern University, Fellowship, Cardiovascular Disease: Chicago, IL (2021)

Board Certifications

• American Board of Internal Medicine, Internal Medicine Board Certification
• American Board of Internal Medicine, Cardiovascular Disease Board Certification

Recognition

• Visiting Research Scholar, The George Institute for Global Health, 2020-2022
• Institute of Global Health Post-Graduate Fellowship in Global Health, Northwestern University Feinberg School of Medicine, 2020-2021
• Robert O. Bonow Research Award, Northwestern University Feinberg School of Medicine, 2019
• World Heart Federation Salim Yusuf Emerging Leader, 2019
• NIH Fogarty Global Health Fellowship at Centre for Chronic Disease Control, India, 2017-2018
• STEAD Research Grant Award, Duke University, 2016
• Doris Duke International Clinical Research Fellowship at Moi University, Kenya, 2013-2014
• Mary Duke Biddle Clinical Scholar in Nepal, Stanford University School of Medicine, 2013
• Medical Scholars Research Award, Stanford University School of Medicine, 2010

Clinical Interests

I am a general non-invasive cardiologist with clinical expertise in prevention of cardiovascular disease. I see patients with a wide variety of cardiovascular diseases and attend on the inpatient cardiology and cardiology consultative service at Barnes-Jewish Hospital.

Research Interests

I am a global cardiovascular physician-scientist with research expertise in global heart failure, clinical trials, and implementation science. I aim to develop, implement, and scale evidence-based interventions to improve the cardiovascular health of undertreated populations globally, including in low- and middle-income countries and the United States.